A Aguilera - Concepedia

Author

A Aguilera

Hospital Universitario La Paz

Also Known As

A Aguilera, A. Aguilera, Abelardo Aguilera, Alexandre Aguilera, Ana Castañeda Aguilera, Ana Castañeda Aguilera

Publications

871

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario La Paz Hospital Universitario de La Princesa University of Oxford

About

A Aguilera is an author at Hospital Universitario La Paz specializing in medicine, nephrology, and urology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	444
2	Health Sciences	2	2	63
3	Cell Biology	2	2	186
4	Cellular Physiology	2	2	186
5	Clinical Nutrition	2	2	63

A Aguilera

Publications

836

Citations

H-Index

Page 1

	Year	Citations
Epithelial-to-mesenchymal transition of mesothelial cells is an early event during peritoneal dialysis and is associated with high peritoneal transport Gloria del Peso, José A. Jiménez‐Heffernan, M. Auxiliadora Bajo, Kidney International Peritoneal DialysisMedicinePathologyEpithelial-mesenchymal InteractionsCell Migration	2008	140
Anorexigen (TNF-&agr; cholecystokinin) and orexigen (neuropeptide Y) plasma levels in peritoneal dialysis (PD) patients: their relationship with nutritional parameters A Aguilera Nephrology Dialysis Transplantation	1998	129
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial PK Judge, Natalie Staplin, KJ Mayne, The Lancet Diabetes & Endocrinology	2023	88
Low-GDP peritoneal dialysis fluid ('balance') has less impact in vitro and ex vivo on epithelial-to-mesenchymal transition (EMT) of mesothelial cells than a standard fluid M. Auxiliadora Bajo, Marı́a Luisa Lozano, Patricia Albar-Vizcaíno, Nephrology Dialysis Transplantation	2010	84
Recombinant human growth hormone therapy in malnourished dialysis patients: A randomized controlled study Pedro Iglesias, Díez Jj, María José Fernández‐Reyes, American Journal of Kidney Diseases HemodialysisGrowth HormoneMalnourished Dialysis PatientsHuman GrowthMedicine	1998	80
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial Natalie Staplin, Richard Haynes, PK Judge, The Lancet Diabetes & Endocrinology	2023	74
Androgen versus erythropoietin for the treatment of anemia in hemodialyzed patients J.L. Teruel, R. Marcén, A Aguilera, Journal of the American Society of Nephrology AnemiaUrologyAndrologyBlood PressureHemodialyzed Patients	1996	55
Effects of Rapamycin on the Epithelial-to-mesenchymal Transition of Human Peritoneal Mesothelial Cells A Aguilera, Luiz Stark Aroeira, Marta Ramírez‐Huesca, The International Journal of Artificial Organs ImmunologyPathologyCellular PhysiologyRegenerative MedicineInflammation	2005	46
Ghrelin plasma levels and appetite in peritoneal dialysis patients. A Aguilera, Antonio Cirugeda, R Amair, PubMed NutritionDialysis TherapyAnorexia-associated MalnutritionObesityMetabolic Syndrome	2004	37
Peritoneal dialysis is the therapy of choice for end-stage renal disease patients with hereditary clotting disorders. M. Auxiliadora Bajo, G del Peso, A Aguilera, PubMed DialysisDialysis TherapyThrombosisGlomerulonephritisRenal Function	2000	32

Page 1